Nazim Uddin Emon

OverviewAI-generated summary

Nazim Uddin Emon's research focuses on the pharmacological potentials of natural products and their application in various health conditions. His work investigates compounds derived from plants and mushrooms, exploring their antioxidant, antimicrobial, and anti-inflammatory properties through in vivo, in vitro, and in silico methodologies. Emon has published on the therapeutic applications of flavonoids, alkaloids like papaverine, and extracts from plants such as Piper nigrum, Colocasia gigantea, Caesalpinia digyna, Lygodium microphyllum, and wild mushrooms.

His research extends to understanding disease mechanisms, including the role of the gut microbiome in autism spectrum disorder. Emon employs computational approaches, such as molecular docking simulations, to assess the binding affinity of phytochemicals to specific biological targets, including COX-1, COX-2, mPGES-1, human erythrocyte catalase, and human glutathione reductase. He also leads a research group and is affiliated with the Arkansas Integrative Metabolic Research Center (AIMRC).

With an h-index of 21 and over 1,500 citations across 55 publications, Emon is recognized as a highly cited researcher. His academic background includes Pharmaceutical Science and Molecular Biology, and he is a doctoral student at the University of Arkansas at Fayetteville. He is a member of the American Society for Biochemistry and Molecular Biology (ASBMB) and the American Society for Microbiology (ASM).

Metrics

• h-index: 21
• Publications: 55
• Citations: 1,560